News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
The firms will offer SARS-CoV-2 testing using a rapid, on-site device as well as lab-based test services.
The GenomeWeb Index rose more than 9 percent in May, following an 18 percent climb in April, a marked contrast to its negative performance in February and March.
The template describes the data and information that should be submitted for EUA of collection kits or tests with a home self-collection component.
The company said that a large portion of the offering's proceeds would be used to end criminal and civil investigations over its past billing practices.
The test uses a proprietary at-home PCR nasal swab test with a turnaround time of 24 hours and is authorized for use by at-risk people.
